Boston Scientific to Participate in 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum
MARLBOROUGH, Mass. /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City.
David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.
About Boston Scientific
SOURCE Boston Scientific Corporation
Company Codes: NYSE:BSX